ReviewAnti-cancer agents in medicinal chemistry2026

Unraveling the Resistance: Challenges and Advances in PARP Inhibitor Therapy for BRCA1/2 Breast Cancer.

Hongjun Tang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.